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Cattle with increased severity of bovine respiratory disease complex
exhibit decreased capacity to protect against histone cytotoxicity1,2
J. A. Matera,* B. K. Wilson,* J. A. Hernandez Gifford,* D. L. Step,# C. R. Krehbiel,* and C. A. Gifford*3
*Department of Animal Science, Oklahoma State University, Stillwater, 74078; and #Department
of Veterinary Clinical Sciences, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, 74078

ABSTRACT: Bovine respiratory disease complex
(BRDC) is the leading cause of morbidity and mortality in feedlot cattle. Significant inflammation and
lesions are often observed in lungs of infected cattle.
During acute inflammatory responses, histones contribute to mortality in rodents and humans and serum
proteins can protect against histone-induced cytotoxicity. We hypothesized that cattle experiencing chronic
or fatal cases of BRDC have reduced ability to protect
against cytotoxic effects of histones. Serum samples
were collected from 66 bull calves at the time of normal feedlot processing procedures. Animals were
retrospectively assigned to groups consisting of calves
never treated for BRDC (control [CONT]; n = 10),
calves treated with antimicrobials once for BRDC (1T;
n = 16), calves treated twice for BRDC (2T; n = 13),
calves treated 3 times for BRDC (3T; n = 14), or calves
treated 4 times for BRDC (4T; n = 13). Samples were
also collected each time animals received antimicrobial treatment; animals within a group were further
sorted by calves that recovered and calves that died to
test histone cytotoxicity. Bovine kidney cells were cultured in duplicate in 96-well plates and exposed to 0
or 50 μg/mL of total histones for 18 h with 1% serum
from each animal. Cell viability was assessed by the

addition of resazurin for 6 h followed by fluorescent
quantification. Fluorescent values from serum alone
were subtracted from values obtained for histone treatment for each animal. Serum from CONT, 1T, and 2T
at initial processing all exhibited a similar (P > 0.10)
response to histone treatment with fluorescent values
of –312 ± 557, –1,059 ± 441, and –975 ± 489, respectively. However, 3T and 4T demonstrated an impaired
capacity (P < 0.05) to protect against histones (–2,778 ±
471 and –3,026 ± 489) at initial processing when
compared to the other groups. When sorted by mortality within group, calves that were treated twice and
recovered (–847 ± 331) demonstrated a greater (P <
0.05) protective capacity than calves that were treated
twice and died (–2,264 ± 412), indicating that calves
that contract BRDC and ultimately die might have
reduced protective capacity against histone cytotoxicity. Results suggest that calves that require multiple
treatments for BRDC have reduced ability to protect
against cytotoxicity of histones. Understanding the
primary mechanism responsible for protecting against
histone cytotoxicity could lead to improved identification of animals susceptible to severe cases of BRDC,
improved focus and use of available resources, or better treatments for severe cases of BRDC.
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Bovine respiratory disease complex (BRDC) is
the largest economic problem facing the U.S. cattle
industry. Annual economic losses due to death, decreased feed efficiency, and treatment costs associated with BRDC are estimated at US$800 to $900
million (Chirase et al., 2001) and BRDC accounts for
approximately 75% of feedlot morbidity and from 50
to 80% of mortality (Edwards, 1996; Chirase et al.,
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2001). Typically, BRDC involves a combination of a
viral and bacterial coinfection. Adding to the complexity, not all animals exposed to these pathogens exhibit
clinical signs. The disease process can develop sepsis;
however, physiological traits for increased susceptibility or increased severity of BRDC remain unclear.
Recently, in humans and mice, extracellular histones have been shown to be involved in death associated with a variety of pathologies including acute sepsis
and injury (Xu et al., 2009, 2011). Moreover, histones
are lethal when injected into mice (Xu et al., 2011),
and serum appears to protect against histone cytotoxicity (Wang et al., 1999). Several serum proteins have
demonstrated the ability to bind to histones, and work
by Abrams et al. (2013) demonstrated that C-reactive
protein (CRP) binds to and neutralizes histone toxicity. Therefore, we hypothesize that histone cytotoxicity
contributes to the severity of BRDC and that cattle exhibit varying degrees of protective capacity against the
cytotoxic effects of histones. The objectives of the current study were to establish an in vitro assay to test protective capacity of serum collected from feedlot cattle
against cytotoxic effects of histones and to determine
if protective capacity in cattle varies in relation to the
degree of severity of naturally acquired BRDC.
MATERIALS AND METHODS
All procedures for the present experiment were approved by the Oklahoma State University Institutional
Animal Care and Use Committee (Animal Care and
Use Protocol AG-12-11).
Animals
Over a 1-wk period, 355 bulls (BW at arrival =
217 ± 20 kg) were purchased from multiple livestock auctions throughout Oklahoma and transported
(average distance = 135 km) to the Willard Sparks
Beef Research Center at Oklahoma State University
(Stillwater, OK). Upon arrival, calves were visually
inspected for abnormalities or illness and subsequently uniquely identified and placed in pens with ad libitum access to hay and water. Calves were allowed
to rest 24 to 48 h before initial processing. Initial
processing included vaccination against infectious
bovine rhinotracheitis virus, bovine viral diarrhea virus types 1 and 2, parainfluenza 3 virus, and bovine
respiratory syncytial virus (BRD Shield; Novartis,
Greensboro, NC); Clostridium chauvoei, Clostridium
septicum, Clostridium novyi, Clostridium sordellii,
and Clostridium perfringens Types C and D (Caliber
7; Boehringer-Ingelheim, St. Joseph, MO); and treatment for the control of internal and external parasites

(Ivomec Plus; Merial, Duluth, GA). Animals were
surgically castrated by incising the scrotum with a
Newberry castrating knife and then emasculation of
the cord. Animals were monitored daily for clinical
symptoms of BRDC.
The evaluation used criteria based on the depression, appetite, respiration and temperature
(DART) system (Pharmacia Upjohn Animal Health,
Kalamazoo, MI) with some modifications as described
by Step et al. (2008). The subjective criteria used for
pulling calves consisted of depression, abnormal appetite, and respiratory signs. The evaluators assigned
a calf a severity score from 0 to 4 based on the clinical signs and the severity of those signs. A score of
0 was assigned for a clinically normal appearing calf.
A score of 1 was assigned for mild clinical signs, 2
for moderate clinical signs, 3 for severe clinical signs,
and 4 for a moribund animal. The objective criteria
used to determine if antimicrobial treatment was necessary was rectal temperature. All calves assigned a
severity score of 1 to 4 were taken to the processing
chute for rectal temperature measurement (GL M-500
thermometer; GLA Agricultural Electronics, San Luis
Obispo, CA). Any animal that was pulled with a severity score of 1 or 2 and had a rectal temperature of
40°C or greater received an antimicrobial treatment
according to label instructions. Any animal with severe clinical signs (severity score = 3 or 4) received
an antimicrobial according to label instructions regardless of rectal temperature. For the first antimicrobial treatment, gamithromycin 150 mg/mL (Zactran;
Merial) was administered at 1 mL/24.9 kg of BW.
After 240 h for calves with a severity score of 1 or
2 and 96 h for calves with a severity score of 3 or 4,
florfenicol 300 mg/mL (Nuflor; Intervet/ScheringPlough, Desoto, KS) was administered at the rate of
1 mL/7.56 kg of BW. After 96 h after the florfenicol
treatment, calves displaying severity scores of 1 or
greater were administered ceftiofur crystalline free
acid 200 mg/mL (Excede; Pfizer, New York, NY) at
1 mL/30.2 kg of BW. A 168 h moratorium was observed before administering a fourth antimicrobial
treatment (ceftiofur; same dose as described above) as
necessary. Postmortem necropsy was also performed
on 3 random calves that died on different days within
2 wk after arrival. This included nasal passage swabs
and lung tissue sampling. Samples were evaluated
by Oklahoma Animal Disease Diagnostic Lab Center
for Veterinary Health Sciences at Oklahoma State
University (Stillwater, OK).
A subset of 66 bulls was retrospectively assigned
to groups consisting of control (CONT; n = 10),
calves treated with antimicrobials once for BRDC
(1T; n = 16), calves treated twice for BRDC (2T; n
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= 13), calves treated 3 times for BRDC (3T; n = 14),
and calves treated 4 times for BRDC (4T; n = 13). For
within-group analysis, each group was separated into
calves that recovered (R) and calves that died (D), resulting in 8 different groups (calves that were treated
once and recovered [1TR; n = 9] or died [1TD; n =
7], calves that were treated twice and recovered [2TR;
n = 6] or died [2TD; n = 7], calves that were treated 3
times and recovered [3TR; n = 6] or recovered [3TD;
n = 8], and calves that were treated 4 times and recovered [4TR; n = 8] or died [4TD; n = 5]).
Serum Collection
Serum was collected at initial processing and each
time a calf met the criteria for the standard feedlot definition for treatment of BRDC. A blood sample (9 mL) was
collected via jugular venipuncture for subsequent serum
analysis (Corvac Serum Separator Tube; Tyco Healthcare
Group LP, Mansfield MA). Blood samples were allowed
to clot at 4°C overnight and then centrifuged at 1,200 ×
g for 15 min at 4°C. The separated serum was placed in
new tubes and frozen at –80°C until analysis.
Cell Culture
Immortal bovine kidney epithelial cells (MadinDarby bovine kidney [MDBK]) cells were cultured in
phenol-free media (Dulbecco’s Modified Eagle Medium
Nutrient Mixture F-12 [DMEM/F12; Life Technologies,
Carlsbad, CA] supplemented with 5% fetal bovine serum [Invitrogen, Carlsbad, CA] and 1% (vol/vol) 100 IU/
mL penicillin and 100 μg/mL streptomycin [Invitrogen]).
Cells were incubated at 38.5°C for a minimum of 24 h.
Cells were plated into 96-well culture plates at a confluency of 20% and allowed to attach overnight in complete
media. After cells attached, media and unattached cells
were removed and cells were incubated in serum-free
media (DMEM/F12 + antibiotics) in the presence of histones or water control (autoclaved, double deionized water, pH 7.1) and the serum sample.
Histone and Serum Dose Response
To determine the lowest dose of total histones
necessary to elicit cytotoxic activity, a histone doseresponse was conducted. Initial doses were selected
based on previous work demonstrating histone cytotoxicity and serum histone levels in disease (Xu et
al., 2009; Abrams et al., 2013). The MDBK cells were
treated with a concentration of 0 (control), 25, 50, 100,
and 200 μg/mL of total calf thymus histones (Santa
Cruz Biotechnology, Dallas, TX) in serum-free media.
Cytotoxicity was determined via visual appraisal and
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resazurin assay as an indicator of cell health (alamarBlue; Life Technologies). The 50 μg/mL of histones
resulted in substantial cell death and was selected for
subsequent studies (see results). The MDBK cells were
then treated with 50 μg/mL of calf thymus histones
and serum-free media supplemented with serum from
calves not displaying symptoms of BRDC. Serum concentrations of 0, 1, 3, and 5% were tested with serum
from 2 separate control animals (cattle with known
background that never displayed clinical symptoms of
injury or illness and exhibited protective capacity in
preliminary experiments). Cell viability was estimated
using alamarBlue (Life Technologies) according to
manufacturer’s recommendations and fluorescence
was detected using a Molecular Devices M3 (Molecular
Devices, Sunnyvale, CA) plate reader. Cells were incubated with treatment for 18 h and exposed to resazurin
for 6 h before reading. Finally, a serum concentration
× histone dose response was evaluated using 0.5 and
1% serum and 50 and 100 μg/mL total histones. A serum concentration of 1% and histone concentration of
50 μg/mL was used for subsequent testing. This level
of histones was chosen because higher concentrations
could have cytotoxic effects despite serum. Likewise,
1% serum was used because the lowest concentration
that conferred protection would also be more susceptible to histone cytotoxicity if animal variation in protective capacity existed.
Serum Protective Capacity Assay
Immortal bovine kidney epithelial cells were cultured as described above. Following overnight attachment, cells were incubated with serum-free media +
1% serum from individual calves + vehicle (control)
in duplicate wells of a 96-well plate to test for serum
effects; duplicate wells were also incubated with phenol serum-free media + 1% serum from individual
calves + 50 μg/mL calf thymus histones. Cells were
incubated with treatment for 18 h and exposed to resazurin for 6 h before reading. Subsequently, fluorescent values for duplicates were averaged and serum +
vehicle was subtracted from serum + histones for each
animal. To evaluate potential toxicity of serum alone,
each animal’s vehicle sample was also compared with
fluorescent values from nontreated cells.
Statistics
Fluorescent values from serum samples collected at
initial processing and incubated without histones were
analyzed using the GLM procedure of SAS (SAS Inst.
Inc., Cary, NC) for CONT, 1T, 2T, 3T, and 4T and fluorescent means were estimated with the PDIFF function.
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Each animal’s normalized fluorescent value estimating histone cytotoxicity (fluorescent value for
serum with histones – serum without histones; delta
fluorescence) for serum samples collected at initial processing was analyzed using the GLM procedure of SAS
for CONT, 1T, 2T, 3T, and 4T. Means were estimated
using the PDIFF function and data are presented as least
squares means ± most conservative within-group SE.
To analyze histone protective capacity over time
in the feedlot, animals that recovered were compared
to animals that died within treatment group (1TR vs.
1TD, 2TR vs. 2TD, 3TR vs. 3TD, and 4TR vs. 4TD).
Serum samples were collected each time an animal
received antibiotic therapy for BRDC and mortality
versus recovery was considered treatment. The delta
fluorescence was tested against treatment, time, and
treatment × time for each group using the MIXED
procedure of SAS. Three covariance structures were
tested for optimal fit statistics and compound symmetry was chosen. Data are presented as least squares
means ± most conservative within-group SE. For all
experiments, significance was set at P < 0.10.
RESULTS

Figure 1. Bovine kidney epithelial cells treated with varying concentrations (0, 25, 50, and 100 μg/mL) of total histones from calf thymus in
media containing no serum or serum from control calves (never displayed
clinical symptoms of illness; n = 2). Control serum was administered at 0,
0.5, and 1% with each histone concentration. Resazurin assay was used
as an estimate of cell viability and fluorescent values were obtained 24 h
after treatment with histones and serum. The change in fluorescence was
calculated with the average of 0 μg/mL of histones as the baseline for each
serum concentration. This baseline was subtracted from the corresponding
serum concentration at greater histone concentrations to give the change in
cell viability due to histone effect. The objective of the experiment was to
determine the lowest concentration of serum and lowest dose of histones
required to exhibit fluorescent values comparable to control. As in previous experiments (data not shown), results demonstrated that 50 μg/mL of
histones was required to induce substantial cell death and 1% serum was
required to fully protect against 50 μg/mL total histones.

A marginal decline in MDBK cell viability was
demonstrated in cells exposed to 25 μg/mL histones.
Increased doses of histones (50 or 100 μg/mL) resulted
in a substantial decline in cell viability but there was
no difference between 50 or 100 μg/mL (Fig. 1). This
devastating response to histones was visually evident
as well. Microscopically, 50 μg/mL histones caused
significant cell death (Fig. 2). As the lowest dose inducing substantial cell death, 50 μg/mL of histones
was used for subsequent serum optimization.
Concentrations of 0, 1, 3, and 5% serum from 2
healthy calves were used in 2 separate assays to evaluate serum protective capacity against 50 μg/mL histones. Data are presented as percent of controls (cells
without histones and serum). Without serum, 50 μg/
mL histones caused a reduction in cell viability, but
addition of the nominal 1% serum restored viability to levels near the histone-free control (Fig. 1). To
further refine the serum protective capacity assay, a
serum by dose-response experiment was conducted.
Healthy calf serum concentrations of 0, 0.5, and 1%
were tested against 0, 25, 50, and 100 μg/mL of histones (Fig. 1). The 0% serum concentration showed a
response similar to previous optimization steps where
50 and 100 μg/mL histones were extremely toxic to
cells. However, no difference was observed between
50 and 100 μg/mL histones. Although 0.5% serum
did decrease histone cytotoxicity relative to nonserum samples, this percent was not able to fully pro-

tect against histone cytotoxicity. However, 1% serum
restored fluorescent values in 50 and 100 μg/mL of
histones to near control (histone-free serum) levels.
Because 1% serum was the lowest concentration of serum that conferred resistance and 50 μg/mL histones
was the lowest dose required to induce cytotoxicity,
these were chosen to test the protective capacity of serum in experimental animals.
Serum samples from CONT, 1T, 2T, 3T, and 4T
collected at initial processing were evaluated using the
resazurin assay. Fluorescent values were obtained in
the absence of histone treatment and in the presence
of 1% serum for each animal to evaluate toxicity effects of the serum alone and to provide a baseline value
for each individual animal. In the absence of histones,
there was no difference (P > 0.20) in fluorescent values
between any of the groups, indicating that there were
no toxicity effects of serum alone (Fig. 3A); additionally, there was no difference between serum-treated
samples and nontreated cells (data not shown). Cells
incubated with 50 μg/mL of histones did not differ in
CONT, 1T, and 2T (P > 0.20). However, calves that
required 3 or more treatments for BRDC exhibited a
decreased (P < 0.05) capacity to protect against histone
cytotoxicity compared with CONT (Fig. 3B) at initial
processing. Relative to their own serum sample tested
without histones, serum from 3T and 4T had fluorescent
values of –2,778 ± 471 and –3,025 ± 489, respectively,
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Figure 2. Bovine kidney epithelial cells were treated with 1% serum of representative protective (against histone cytotoxicity) and nonprotective
calves and with or without 50 μg/mL total histones. Calves were classified as protective or nonprotective based on previous experiments. Pictures of cells
in culture were taken after 24 h treatment with histones, serum, or both. Column A: Cells treated with 1% serum and no histones from a representative
protective animal (top) and a representative nonprotective animal (bottom). Column B: Cells treated with 50 μg/mL of histones and 1% serum from a representative protective animal (top) and a representative nonprotective animal (bottom). Column C: Cells treated with 50 μg/mL of histones and no serum.

when incubated with 50 μg/mL histones. Serum samples from CONT were able to protect against histone
toxicity and had fluorescent values near their own nonhistone baseline (–312 ± 557; Fig. 3B). Calves treated
with antimicrobials once for BRDC and 2T displayed
protective capacities similar to (P > 0.10) CONT and
were approximately –1,000 for both groups.
Serum samples were also collected each time an
animal received antimicrobial treatment for BRDC,
and those that required treatment for BRDC were sorted within group (i.e., 1T, 2T, 3T, or 4T) by calves that
recovered and calves that died. To determine if protective capacity against histone cytotoxicity changed
between calves that lived and those that died, serum
samples within group were analyzed against time,
treatment (recovered or died), and treatment × time
interactions. For 1T, 3T, or 4T, there was no effect of
mortality or time on the protective capacity against
histones (P > 0.10; Fig. 4A, 4C, and 4D). However,
there was a treatment effect for the 2T group. Calves
that were treated twice for BRDC and recovered had a
greater (P < 0.05) overall protective capacity than 2T
that ended up dying (Fig. 4B).

DISCUSSION
Bovine respiratory disease complex remains the
main cause of morbidity and mortality in feedlot cattle.
Despite much research effort, BRDC cases have been
relatively constant over the past 30 yr (reviewed by
Gifford et al., 2012) and contribute to decreased economic returns due to treatment costs, decreased carcass
quality, depressed growth, and death loss. Bovine respiratory disease complex is a multifaceted disease and
the etiological agents are typically viral and bacterial or
mycoplasmal. The most common viral agents observed
are bovine herpesvirus 1, bovine parainfluenza virus 3,
bovine viral diarrhea virus 1 and 2, bovine coronavirus, and bovine adenovirus; typical bacterial agents are
Mannheimia haemolytica, Pasteurella multocida, and
Histophilus somni (reviewed by Griffin et al., 2010).
Mycoplasma species can also be pathogens in BRDC
outbreaks (reviewed by Griffin et al., 2010). Although
pathogens can vary in cases of BRDC, a hallmark of the
disease is respiratory tract infections resulting in pneumonia and bronchiolar lesions (Fulton et al., 2009). In the
current study, postmortem necropsy of 3 calves identified
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Figure 3. A. Serum samples were collected from 66 bulls at initial
processing. Animals were retrospectively assigned to groups consisting
of calves that never received antibiotic treatment for bovine respiratory
disease complex (BRDC; CONT; n = 10), calves treated with antimicrobials once for BRDC (1T; n = 16), treated twice for BRDC (2T; n = 13),
calves treated 3 times for BRDC (3T; n = 14), or calves treated 4 times for
BRDC (4T; n = 13). A) For each animal, 1% serum was incubated alone
on bovine kidney epithelial cells (MDBK cells). Resazurin assay was used
as an estimate of cell viability and fluorescent values were obtained 24
h after treatment with serum. Data for the 1% serum alone baseline was
evaluated using GLM procedure with no significance (P > 0.20) between
groups. Results show that serum alone collected at initial processing is not
cytotoxic. B) For each animal, 1% serum was incubated alone and in combination with 50 μg/mL of histones on MDBK cells. Resazurin assay was
used as an estimate of cell viability and fluorescent values were obtained
24 h after treatment with histones. Data from each animal’s fluorescent
value obtained from serum without histones served as a baseline for that
animal. Baseline values were subtracted from respective fluorescent values
obtained from incubating MDBK cells with serum + histones. Data are
presented as least squares means ± most conservative within-group SE.
Columns with different letters indicates significance (P < 0.05). Results
show that calves that require multiple treatments for BRDC exhibit a decreased capacity to protect against histone cytotoxicity.

several pathogens including Mannheimia haemolytica,
Mycoplasma bovis, bovine viral diarrhea virus, Bovine
coronavirus, and Pasteurella multocida and calves exhibited greater than 85% lung damage. Additionally,
the severity of the disease varied both in length (calves
requiring only 1 antimicrobial treatment up to 4 treatments) of clinical signs and varied times to death (calves
that died after 1 treatment, 2 treatments, 3 treatments, or
4 treatments). The varied severity of disease likely stems

from variation of individual resistance (Snowder et al.,
2006) and the multiple pathogens involved (Fulton et al.,
2009; Kirchhoff et al., 2014). However, for all groups in
the current study, the average time to first treatment was
6 ± 1.5 d, indicating that all animals suffered similar exposure on arrival. Ultimately, the resulting experimental
group had calves that exhibited varied severity of BRDC
ranging from acute to chronic.
Pathologies that induce necrosis (either acute or
chronic) or, in some cases, apoptosis cause release of
histones into the extracellular spaces (Xu et al., 2009).
Histone proteins (H1, H2A, H2B, H3, H4, and H5)
help maintain the highly organized structure of DNA
in chromatin format within the nucleus of eukaryotic
cells. A nucleosome consists of 1 H3/H4 tetramer and
2 H2A/H2B dimers; this histone octomer coils 147 bp
of DNA. Together with the linker histones, H1 and H5,
nucleosomes form higher order chromatin structures
(Felsenfeld and Groudine, 2003). In human patients
with acute respiratory distress syndrome and in mice
with experimentally induced acute lung injury, extracellular histones are detected in bronchoalveolar lavage fluid (Ward and Grailer, 2014). Likewise, Wen et
al. (2013) demonstrated increased circulating histones
in a mouse model for acute liver failure and sourced
the histones to apoptotic hepatocytes and infiltrating
neutrophils. Additionally, there are numerous other diseases and injuries that can cause a rise in circulating
histone levels of humans, mice, and baboons (reviewed
by Allam et al., 2014), but studies in cattle experiencing BRDC are lacking. Typically, lung damage occurs
during episodes of BRDC and other species that suffer
acute respiratory damage from disease or injury exhibit
a rise in extracellular histones; it is reasonable to speculate that histones are released during BRDC as well. In
the current experiment, serum samples were harvested
and stored according to normal laboratory procedures.
However, nucleosomes in serum are degraded relatively quickly and require stabilization with EDTA to
reliably quantify nucleosomes/histones after freezing
samples (Holdenrieder et al., 2001). Moreover, samples
must be harvested and processed in a similar manner,
preferably in under 2 h (Holdenrieder et al., 2001). The
samples collected for these data were allowed to clot
overnight at 4°C and were not stabilized with EDTA;
therefore, it seemed unlikely that circulating histones
could be accurately quantified in these samples. If there
were increased serum histones in some samples at arrival, it would seem likely those serum samples would be
cytotoxic to MDBK cells. There were no detectable differences in cytotoxicity of serum samples from any of
the groups at initial processing, indicating that histones
or other factors in the samples were not contributing to
the observed cytotoxicity.
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Figure 4. Serum samples were collected from 66 bulls at initial processing (IP) and at each treatment with antimicrobials for bovine respiratory disease
complex (BRDC). Calves (n = 10) that never received treatment for BRDC are not included in figure. Animals were retrospectively assigned to groups consisting of calves treated once for BRDC (n = 16), treated twice for BRDC (n = 13), calves that received 3 treatments for BRDC (n = 14), or calves that received 4
treatments for BRDC (n = 13). Within each group, calves were further assigned as dead after last treatment (D; dashed lines) or recovered after last treatment
(R; solid lines). Calves receiving the same total number of treatments were compared across their respective treatments. Samples collected at each treatment
are designated as 1T (calves treated with antimicrobials once for BRDC), 2T (calves treated twice for BRDC), 3T (calves treated 3 times for BRDC), and 4T
(calves treated 4 times for BRDC). For each animal, 1% serum was incubated alone and in combination with 50 μg/mL of histones on bovine kidney epithelial
cells (MDBK cells). Resazurin assay was used as an estimate of cell viability and fluorescent values were obtained 24 h after treatment with histones. Each
animal’s fluorescent value was calculated with serum without histones serving as a baseline for that animal. Baseline values were subtracted from fluorescent
values obtained from incubating MDBK cells with serum + histones. A) Calves that were treated once and died (1TD; n = 7) or recovered (1TR; n = 9). There
was no effect of mortality (P > 0.10) on serum protective capacity between calves that recovered and those that died. B) Calves that were treated twice and
died (2TD; n = 7) or recovered (2TR; n = 6). There was an overall effect of mortality on histone protective capacity (P < 0.05). Overall, 2TD had a decreased
capacity to protect against histone toxicity compared with 2TR. C) Calves that were treated 3 times and died (3TD; n = 8) or recovered (3TR; n = 6). Overall
histone protective capacity was similar for those that died versus those that recovered. D) Calves that were treated 4 times and died (4TD; n = 5) or recovered
(4TR; n = 8). Although initially similar, after 1 treatment 4TD began to show a numerical decline in protective capacity whereas 4TR had a numerical increase
in protection against histones after 3 treatments. Nonetheless, there was no overall difference (P > 0.20) between calves that died and those that recovered.

The physiological significance of extracellular
histones in disease was first demonstrated by Xu et al.
(2009), in which an inflammatory challenge led to a rise
in extracellular histones and resulted in organ failure
and ultimately death during sepsis. Exogenous histones
administered intravenously to mice also elicit a hyperinflammatory response leading to cell damage and
animal death (Xu et al., 2009). Intratracheal administration of histones greatly induces inflammation leading
to epithelial damage, lung consolidation, and death in
some cases (Ward and Grailer, 2014). In the absence of
serum, we also observed complete cell death in MDBK
cells treated with histones. However, histones not only
directly induce cell death but can also hyperstimulate
the proinflammatory response during a variety of conditions including acute liver failure (Wen et al., 2013).

During systemic inflammatory responses from disease
or injury, it appears that histones bind toll-like receptors
(TLR). Using a subfatal dose of histones administered
to mice, Xu et al. (2011) found evidence of TLR2 and
TLR4 signaling. Furthermore, when injected with exogenous histones, TLR4 knockout mice did not show
massive proinflammatory cytokine production. This
evidence, in addition to an in vitro model showing direct activation of TLR by exogenous histone treatment,
strongly implicates the importance of TLR in histoneinduced cytokine production and direct cell or organ
damage (Xu et al., 2011).
Increasing evidence supports that there are physiological adaptations to protect against histone toxicity.
Aside from identifying extracellular histones as cytotoxic, Xu et al. (2009) noted that activated protein-c
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infusion in combination with histones protected mice
from the lethal effects of exogenous histones. Treatment
with CRP also protected mice from lethal doses of exogenous histones (Abrams et al., 2013). Pemberton et
al. (2010) found numerous serum proteins, including
the acute phase protein fibrinogen, that bound histones,
but the protective capacity of these proteins is undetermined. Results in the present study indicate that increasing the concentration of serum greatly decreased
histone toxicity. Collectively, these studies indicate that
serum can protect against histone toxicity and that individuals may exhibit varied levels of protection.
In cattle, there is a varied response to the BRDC
pathogens among individual animals. Although exposure level and specific pathogen can contribute to
varied levels of disease, individual susceptibility may
also be important (Snowder et al., 2006). In the current
study, calves were physically castrated on arrival; thus,
these animals experienced both tissue injury and acute
clinical infection. Although not directly measured, it
would seem these calves would likely exhibit increased
levels of circulating histones. Because histones can
exacerbate inflammation, it is interesting to speculate
that castration might lead to an increase in extracellular
histones. In turn, the extracellular histones might alter
the cytokine profile and, along with the stress response,
make bulls more susceptible to BRDC.
Nonetheless, we reasoned that, similar to other species, calves would demonstrate varying protective capacity against histone toxicity and those that were least
protective would suffer more severe cases of BRDC as
indicated by death or duration of illness. Results indicated that serum samples from calves collected at initial
processing had varied protective capacities against histone cytotoxicity, and calves that ultimately required 3
or more treatments for BRDC were the least protective.
Interestingly, the decreased capacity was observed from
serum samples collected at initial processing and before
clinical symptoms of BRDC. Certainly, larger studies
are necessary, but these data could suggest that histone
toxicity protective capacity might be of use to predict
which calves will exhibit longer durations of clinical disease and require multiple treatments. Because
chronically infected calves experience the most detriment to carcass traits (Holland et al., 2010), perhaps
these animals could be managed differently if identified
early to minimize economic losses. Ideally, the mechanism or mechanisms for histone protective capacity will
be found, leading to new treatments or genetic screening of susceptible individuals.
At initial processing, there was no difference in protective capacity between calves that recovered and those
that died within a group. When groups (1T, 2T, 3T, and
4T) were separated by those that recovered and those that

died, there were no treatment, time, or treatment × time
interactions for histone protective capacity in the 1T, 3T,
and 4T groups. There was a treatment effect for the 2T
group, and animals that recovered displayed greater protection against the cytotoxic effects of histones than those
that died, but studies with a larger sample size would be
necessary to confirm these findings.
We initially predicted that calves that die from
BRDC would have decreased capacity to protect against
histone toxicity. Although not significant, a trend could
be emerging from the current data in which animals
that recover from BRDC display increasing protective capacity whereas those that die show decreased
protective capacity over time. Results from the current
study do not statistically support differences in protective capacity based on mortality, but the concept should
be revisited with larger sample sizes or assays that
directly measure the protective mechanism or mechanisms against histone cytotoxicity. Additionally, serum
histone levels could be quantified in properly handled
serum samples. Certainly, other components of BRDC
are likely contributors to death and histone cytotoxicity
is not the sole contributor to clinical BRDC symptoms.
It is also possible that calves that die have a massive
rise in extracellular histones overriding any protective
capacity; therefore, histone levels as well as protective
capacity can be contributors to death in BRDC. Larger
studies with appropriately processed serum are necessary to describe histone release during BRDC.
In conclusion, as in other species, cattle serum is
able to protect against extracellular histone toxicity.
Additionally, individual animals exhibit a varied capacity to protect against histone cytotoxicity, and calves
that require multiple treatments for BRDC show an
impaired capacity to protect against toxic effects of extracellular histones. Future work is needed to identify
components of the serum that confer protection and to
quantify extracellular histone levels during BRDC.
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